SOLACI-SBHCI 2023 Congress Has Begun!

Let the best begin! After a year of intense work, SOLACI-SBHCI 2023 Congress—the widest, most important event for interventional cardiologists in Latin America—has kicked off.

Until August 4th, the Windsor Hotel in Barra da Tijuca will be the scenario for a high-level scientific program that includes challenging live national and international cases, edited complex clinical cases, over 20 international guests, joint sessions with the most important scientific societies in the world, scientific updates, innovation, technical advancements, stimulating academic debates, and comprehensive coverage of the most relevant topics in our specialty.

All these activities take place in 8 simultaneous thematic rooms and 2 interactive spaces with workshops, simulators, and modern, exciting training spaces. Additionally, there is a commercial exhibit featuring the most important medical industry representatives.

Some of the highlights of this Congress are the ProEducar-SOLACI Interventional Trainees Course, with 13 years of uninterrupted medical education, and the MIL/MINT Symposium for Latin American women in interventional cardiology.

Join us to experience an unforgettable event until August 4th! Enjoy SOLACI-SBHCI 2023!

More articles by this author

Download the Official SOLACI-CACI 2024 Congress APP

  DOWNLOAD THE OFFICIAL APP OF SOLACI-CACI 2024 Next Wednesday marks the beginning of SOLACI-CACI 2024! Download the Congress APP and discover the unmissable program of the...

Survey on Hemodynamics Centers in Latin America – SOLACI, Stent Save a Life! and South American Society of Cardiology Initiative

The treatment of ST-segment elevation myocardial infarction (STEMI) in Latin America is highly diverse. There are notable differences between countries and even among regions...

SOLACI-SBHCI 2023 | AORTIC ANEURYSM FROM THE GUIDELINES TO THE REAL WORLD – Dr. Felix Damas de los Santos

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Felix Damas de los Santos, entitled “Alternative Vascular...

SOLACI-SBHCI 2023 Scientific Coverage – Day 3

The third day of the Congress started at the Copacabana Arena with the International Live Case held at Nanjing First Hospital, Nanjing, China, which...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....